Exploring the application of cost-effectiveness evaluation in the Japanese National Health Insurance System

21 March 2019 - Japan's Central Social Insurance Medical Council (“Chuikyo”) began in 2012 to examine how cost-effectiveness evaluation might ...

Read more →

Japan approves two gene treatments in bid to catch up

21 February 2019 - Potential revolutionary treatments have exorbitant price tags. ...

Read more →

As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices

18 February 2019 - Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether ...

Read more →

MAESTrO Database on exhibit at ISPOR Asia-Pacific Conference

12 August 2018 - Exciting new features to be launched at the conference. ...

Read more →

EU and Japan reinforce their collaboration on inspections of medicine manufacturers

18 July 2018 - Update of 2004 mutual recognition agreement extends scope to sterile products, active pharmaceutical ingredients and biologicals ...

Read more →

FDA faster than global peers at approving new drugs

16 May 2018 - A report from the Centre for Innovation in Regulatory Science released this month finds that the ...

Read more →

Ohara cuts price of generic drug for leukaemia

11 April 2018 - Ohara Pharmaceutical Co. has reduced the price of its generic drug for leukaemia to about half ...

Read more →

Government to cut price of Opdivo by over 20%

5 March 2018 - Japan’s health ministry said Monday that the government-set price of cancer drug Opdivo will be reduced ...

Read more →

Looming tipping point for Japan pharma

15 December 2017 - Changes to Japan’s drug reimbursement system care are inevitable. The only questions are the extent of ...

Read more →

Japan to cut price of infamously expensive cancer drug again

14 December 2017 - Government, which already halved Opdivo price, seeks more cost relief. ...

Read more →

Japan's MHLW presents drug pricing changes

23 November 2017 - Japan's Ministry of Health, Labour and Welfare has proposed changes to its reimbursement policy that would ...

Read more →

Japan to step up price cuts for off-patent drugs

18 November 2017 - New pricing scheme aimed at curbing soaring medical expenses. ...

Read more →

Towards a single development programme for new antibiotics in EU, Japan and US

17 November 2017 - EMA, PMDA and FDA to further align data requirements and explore options to streamline paediatric development. ...

Read more →

Novartis seeks outcomes-based pricing in Japan for cancer drug

5 October 2017 - Swiss pharma's effort could spark broad changes in nation's pricing system. ...

Read more →

Japan health minister to consider U.S. drug firms' views in pricing overhaul

22 September 2017 - Japan will weigh the concerns of U.S. drug firms in its efforts to complete by year-end ...

Read more →